Roche's Profit Surge: Obesity Drug Investments Pay Off?

Roche Raises Profit Forecast Despite Currency Headwinds! The Swiss drugmaker is betting big on obesity drugs to challenge Novo Nordisk and Eli Lilly, fueled by strong underlying performance and a revised, higher profit outlook. Will their bold move pay off, or will they need to adjust their strategy to compete in the booming weight-loss market?The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.